- Trials with a EudraCT protocol (20)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
20 result(s) found for: Vitreous Detachment.
Displaying page 1 of 1.
EudraCT Number: 2014-000388-41 | Sponsor Protocol Number: OZR-2013-27 | Start Date*: 2014-05-05 |
Sponsor Name:The Rotterdam Eye Hospital | ||
Full Title: Does oral administration of dabigatran etexilate, a direct thrombin inhibitor, achieve clinical significant concentrations of dabigatran and thrombin inhibiting activity in vitreous and subretinal ... | ||
Medical condition: Ocular accessibility of dabigatran in patients with retinal detachment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003029-40 | Sponsor Protocol Number: IOBA-01-2016 | Start Date*: 2017-02-14 |
Sponsor Name:IOBA - University of Valladolid | ||
Full Title: Phase II safety assessment of intravitreal injection of mesenchymal stem cells for acute non arteritic anterior ischemic optic neuropathy (NAION) | ||
Medical condition: Non arteritic anterior ischemic optic neuropathy (NAION) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005081-19 | Sponsor Protocol Number: 1 | Start Date*: 2014-07-10 | |||||||||||
Sponsor Name:HOSPICES CIVILS DELYON | |||||||||||||
Full Title: Phase II study evaluating the efficacy of aflibercept for the treatment of idiopathic choroidal neovascularization in young subjects: the INTUITION study | |||||||||||||
Medical condition: idiopathic choroidal neovascularization | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006085-42 | Sponsor Protocol Number: TG-MV-004 | Start Date*: 2007-01-24 | |||||||||||
Sponsor Name:ThromboGenics Ltd. | |||||||||||||
Full Title: A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding, Multicenter Trial of Microplasmin Intravitreal Injection for Non-Surgical PVD Induction for Treatment of ... | |||||||||||||
Medical condition: Vitreomacular Traction Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003640-23 | Sponsor Protocol Number: ECR-RET-2013-05 | Start Date*: 2014-01-13 | |||||||||||
Sponsor Name:AIBILI - Association for Innovation and Biomedical Research on Light and Image | |||||||||||||
Full Title: Prospective, randomized, multicentre, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus PRP ... | |||||||||||||
Medical condition: Patients with type I or type II diabetes mellitus and high risk diabetic retinopathy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002415-15 | Sponsor Protocol Number: TG-MV-015 | Start Date*: 2016-02-17 | |||||||||||
Sponsor Name:ThromboGenics NV | |||||||||||||
Full Title: A PHASE 2, RANDOMISED, DOUBLE-MASKED, SHAM-CONTROLLED, MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OCRIPLASMIN IN INDUCING TOTAL POSTERIOR VITREOUS DETACHMENT (PVD) IN SUBJECTS WITH N... | |||||||||||||
Medical condition: Moderately severe to very severe non-proliferative diabetic retinopathy (NPDR) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Completed) CZ (Completed) BE (Completed) HU (Completed) ES (Completed) FR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004626-93 | Sponsor Protocol Number: TG-MV-002 | Start Date*: 2006-12-19 | |||||||||||
Sponsor Name:ThromboGenics N.V. | |||||||||||||
Full Title: A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding Trial of Microplasmin Intravitreal Injection for Non-Surgical PVD Induction for Treatment of Diabetic Macu... | |||||||||||||
Medical condition: Diabetic macular edema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) NL (Completed) GB (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004393-40 | Sponsor Protocol Number: TG-MV-007 | Start Date*: 2008-12-17 | |||||||||||
Sponsor Name:ThromboGenics NV | |||||||||||||
Full Title: A randomized, placebo controlled, double-masked, multicenter trial of microplasmin intravitreal injection for non-surgical treatment of focal vitreomacular adhesion. | |||||||||||||
Medical condition: Focal Vitreomacular Adhesion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Completed) CZ (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004501-27 | Sponsor Protocol Number: 2183/2019 | Start Date*: 2021-01-28 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Perioperative analgesia in children undergoing ophthalmic surgery | ||
Medical condition: perioperative analgesia | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001060-11 | Sponsor Protocol Number: FSJD-RTB-2015 | Start Date*: 2017-08-03 | |||||||||||
Sponsor Name:Fundació Sant Joan de Déu | |||||||||||||
Full Title: A Phase I, unicentric, open and dose escalation clinical trial to evaluate the safety and the activity of the oncolytic adenovirus VCN-01 in patients with refractory retinoblastoma | |||||||||||||
Medical condition: Refractory Retinoblastoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014409-15 | Sponsor Protocol Number: CRFB002DPT04T | Start Date*: 2010-01-08 | |||||||||||
Sponsor Name:AIBILI - Association for Innovation and Biomedical Research on Light and Image | |||||||||||||
Full Title: Prospective, randomized, multicenter, open label phase II study to access efficacy and safety of Lucentis monotherapy (ranibizumab 0.5 mg intravitreal injections) compared with Lucentis plus panret... | |||||||||||||
Medical condition: Proliferative Diabetic Retinopathy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016760-36 | Sponsor Protocol Number: CC-02-2009 | Start Date*: 2010-02-05 | |||||||||||
Sponsor Name:AIBILI | |||||||||||||
Full Title: Prospective, randomized, open label phase II study to assess efficacy and safety of Macugen® (pegaptanib 0.3 mg intravitreal injections) plus panretinal photocoagulation (PRP) and PRP (monotherapy)... | |||||||||||||
Medical condition: Proliferative Diabetic Retinopathy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023923-78 | Sponsor Protocol Number: FH-1.3 | Start Date*: 2011-03-30 |
Sponsor Name:Forsight Vision 4, Inc. | ||
Full Title: “ A prospective clinical trial to evaluate the V4 Drug delivery device for long term delivery of Ranibizumab for the Treatment of Choroidal Neovascularization” | ||
Medical condition: Choroidal Neovascularization (CNV) secondary to Age-related Macular Degeneration (AMD) is among the leading causes of blindness in the world. The primary treatment modality is injection of Lucentis... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003272-12 | Sponsor Protocol Number: SIVS1012 | Start Date*: 2014-04-08 |
Sponsor Name:Moorfields Eye Hospital | ||
Full Title: Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy | ||
Medical condition: Proliferative Diabetic Retinopathy (PDR) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003243-37 | Sponsor Protocol Number: | Start Date*: 2017-11-02 | |||||||||||||||||||||||||||||||
Sponsor Name:MUST Coordinating Centre, John Hopkins Bloomberg School of Public Health | |||||||||||||||||||||||||||||||||
Full Title: Macular Edema Ranibizumab v. Intravitreal anti-inflammatory Therapy (MERIT) Trial | |||||||||||||||||||||||||||||||||
Medical condition: Uveitic macular oedema | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Temporarily Halted) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000304-29 | Sponsor Protocol Number: | Start Date*: 2016-04-05 | |||||||||||||||||||||||||||||||
Sponsor Name:MUST Coordinating Centre, John Hopkins Bloomberg School of Public Health | |||||||||||||||||||||||||||||||||
Full Title: Periocular and Intravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial | |||||||||||||||||||||||||||||||||
Medical condition: Uveitic macular oedema | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002523-28 | Sponsor Protocol Number: KHAK1001 | Start Date*: 2016-09-16 | |||||||||||
Sponsor Name:Moorfields Eye Hospital | |||||||||||||
Full Title: A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa | |||||||||||||
Medical condition: Retinitis Pigmetosa. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003165-13 | Sponsor Protocol Number: 03 | Start Date*: 2007-02-15 | |||||||||||
Sponsor Name:Dep. Ophthalmology, Medical University of Vienna | |||||||||||||
Full Title: A randomized, double-masked study with intraocular Bevacizumab (Avastin®) compared with non-treatment control in patients with persistent diabetic macular edema or persistent active neovascularisat... | |||||||||||||
Medical condition: persistent diabetic macular edema or persistent active neovascularisation following lasercoagulation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001286-16 | Sponsor Protocol Number: APP-study | Start Date*: 2018-11-05 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Low-dose Atropine for the Prevention of Childhood Myopia Progression in Danish Children (APP-study) | |||||||||||||
Medical condition: Childhood myopia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001064-29 | Sponsor Protocol Number: KS301P106 | Start Date*: 2021-09-26 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Kodiak Sciences Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: A Prospective, Randomized, Double-masked, Sham-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Participants with Moderately Severe to... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Non-proliferative Diabetic Retinopathy (NPDR) | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: SK (Prematurely Ended) ES (Prematurely Ended) LV (Prematurely Ended) CZ (Ongoing) PL (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.